Outrage of the Month: Lessons From the Withdrawal of the Amyotrophic Lateral Sclerosis Drug AMX0035 (RELYVRIO) May 1, 2024
Press Releases Public Citizen Asks CDC and FDA To Revise Recent Health Advisory on Counterfeit or Mishandled Botulinum Toxin Injections April 30, 2024
Letters, Testimony & Filings Letter to the CDC and FDA Regarding Recent Health Advisory on Clusters of Patients with Adverse Events From Certain Botulinum Toxin Injections April 30, 2024
Press Releases CDC Should Promptly Facilitate Administration of Botulinum Antitoxin to People with Illnesses Linked to Counterfeit “Botox” April 17, 2024
Press Releases Manufacturer Withdraws Amyotrophic Lateral Sclerosis Drug AMX0035 (Relyvrio) From Market April 4, 2024